References
Sullivan KE, Calman AF, Nakanishi M, et al: A model for the transcriptional regulation of MHC class II genes. Immunol Today 1987;8:289–293.
Kappes D, Strominger JL: Human class II major histocompatibility complex genes and proteins. Ann Rev Biochem 1988;57:991–1028.
Calman AF, Peterlin BM: Transcriptional regulation of HLA class II genes:Cis-acting elements andtrans-acting factors; in Silver J (ed): Molecular Biology of HLA Class II Antigens. Boca Raton, CRC, 1989, in press.
Hardy DA, Bell JI, Long EO, et al: Mapping of the class II region of the human major histocompatibility complex by pulsed-field gel electrophoresis. Nature 1986;323:453–455.
Lawrance SK, Smith CL, Srivastava R, et al: Megabase-scale mapping of the HLA gene complex by pulsed field gel electrophoresis. Science 1987; 235:1387–1390.
Carroll MC, Katzmann, Alicot EM, et al: Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. Proc Natl Acad Sci USA 1987;84:8535–8539.
Rask L, Andersson G, Andersson L, et al: The evolution of human class II antigens as deduced from sequence analyses; in Schulze D, Kelsoe G (eds): Evolution and Vertebrate Immunity: The Antigen Receptor and MHC Gene Families. Austin, University of Texas Press, Austin, 1987, pp 363–377.
Mathis D, Benoist C, Williams VE II et al: The murine Eα immune response gene. Cell 1983;32:745–754.
Kelly A, Trowsdale J: Complete nucleotide sequence of a functional HLA-DPβ gene and the region between the DPβ1 and DPα1 genes: comparison of the 5′ ends of HLA class II genes. Nucl Acids Res 1985;13:1607–1619.
Okada K, Boss JM, Prentice H, et al: Gene organization of DC and DX subregions of the human major histocompatibility complex. Proc Natl Acad Sci USA 1985;82:3410–3414.
Servenius B, Rask L, Peterson PA: Class II genes of the human major histocompatibility comples: The DOβ gene is a divergent member of the class II β gene family. J Biol Chem 1987;262:8759–8766.
Bottazzo GF, Todd I, Mirakian R, et al: Organ-specific autoimmunity: A 1986 overview. Immunol Rev 1986; 94: 137–169.
Lisowska-Grospierre B, Charron DJ, de Preval C, et al: Defect of expression of MHC genes responsible for an abnormal HLA class I phenotype and the class II negative phenotype of lymphocytes from patients with combined immunodeficiency; in Histocompatibility Testing. Berlin, Springer, 1986, pp 650–655.
Hadam MR, Doepfer R, Peter HH, et al: Congenital agammaglobulinaemia associated with lack of expression of HLA-D-region antigens; in Griscelli C, Vossen J (eds): Progress in Immunodeficiency Research and Therapy. Amsterdam, Excerpta Medica, 1984, pp 43–50.
Peterlin BM, Gonwa TA, Stobo TD: Expression of HLA-DR by a human monocyte cell line is under transcriptional control. J Mol Cell Immunol 1984; 1: 191–200.
Levine F, Pious D: Different roles for cytosine methylation in HLA class II gene expression. Immunogenetics 1985; 22: 427–440.
Reitz M, Mann DL, Eiden M, et al: DNA methylation and expression of HLA-DRα. Mol Cell Biol 1984; 4: 890–897.
Ting JPY, Carrington MN, Salter RD, et al: Evidence for chromatin structure as a regulatory determinant in HLA DR alpha gene expression. Immunogenetics 1985; 22: 571–583.
Wang Y, Peterlin BM: Methylation patterns of HLA-DR alpha genes in six mononuclear cell lines. Immunogenetics 1986; 24: 298–303.
Peterlin BM, Hardy KJ, Larsen AS: Chromatin structure of the HLA-DRα gene in different functional states of major histocompatibility complex class II gene expression. Mol Cell Biol 1987; 7: 1967–1972.
Liou HC, Polla BS, Aragnol D, et al: A tissue specific DNase I-hypersensitive site in a class II Aα gene is undertrans-regulatory control. Proc Natl Acad Sci USA 1988; 85: 2738–2742.
Gönczy P, Reith W, Barras E, et al: Inherited immunodeficiency with a defect in a major histocompatibility complex class II promoter-binding protein differs in the chromatin structure of the HLA-DRA gene. Mol Cell Biol 1989; 9: 296–302.
Doerfler W: DNA methylation and gene activity. Ann Rev Biochem 1983; 52: 93–124.
Weintraub H, Groudine M: Chromosomal subunits in active genes have an altered conformation. Science 1976; 193: 848–856.
Bird AP: CpG-rich islands and the function of DNA methylation. Nature 1986; 321: 209–213.
Khoury G, Gruss P: Enhancer elements. Cell 1983; 33: 313–314.
Ondek B, Gloss L, Herr W: The SV40 enhancer contains two distinct levels of organization. Nature 1988; 333: 40–45.
Breathnach R, Chambon P: Organization and expression of eukaryotic split genes coding for proteins. Ann Rev Biochem 1981; 50: 349–383.
Dorn A, Durand B, Marfing C, et al: Conserved MHC class II boxes X- and Y-are transcriptional control elements and specifically bind nuclear proteins. Proc Natl Acad Sci USA 1987; 84: 6249–6253.
van Ewijk W, Ron Y, Monaco J, et al: Compartmentalization of MHC class II gene expression in transgenic mice. Cell 1988; 53: 357–370.
Widera G, Burkly CA, Pinkert CA, et al: Transgenic mice selectively lacking MHC class II (I-E) antigen expression on B cells: an in vivo approach to investigate Ia gene function. Cell 1987; 51: 175–187.
Gillies SD, Folsom V, Tonegawa S: Cell type-specific enhancer element associated with a mouse MHC gene, Eβ. Nature 1984; 310: 594–597.
Boss J, Strominger JL: Regulation of a transfected human class II major histocompatibility complex gene in human fibroblasts. Proc Natl Acad Sci USA 1986; 83: 9139–9143.
Basta PV, Sherman PA, Ting JPY: Identification of an interferon-γ response region 5′ of the human histocompatibility leukocyte antigen DRα chain gene which is active in human glioblastoma multiforme lines. J Immunol 1987; 138: 1275–1280.
Sherman PA, Basta PV, Ting JPY: Upstream DNA sequences required for tissue specific expression of the HLA-DRα gene. Proc Natl Acad Sci USA 1987; 84: 4254–4258.
Sullivan KE, Peterlin BM: Transcriptional enhancers in the HLA-DQ subregion. Mol Cell Biol 1987; 7: 3315–3319.
Wang Y, Larsen AS, Peterlin BM: A tissue-specific transcriptional enhancer is found in the body of the HLA-DRα gene. J Exp Med 1987; 166: 625–636.
Basta PV, Sherman PA, Ting JPY: Detailed delineation of an interferon-γ-responsive element important in human HLA-DRA gene expression in a glioblastoma multiforme line. Proc Natl Acad Sci USA 1988; 85: 8618–8622.
Mavrothalassitis GJ, Thanos D, Papamatheakis J: Molecular analysis of the mouse class II gene, Eα. Immunogenetics 1988; 27: 426–430.
Sloan JH, Boss JM: Conserved upstream sequences of human class II major histocompatibility genes enhance expression of class II genes in wild-type but not mutant B-cell lines. Proc Natl Acad Sci USA 1988; 85: 8186–8190.
Thanos D, Mavrothalassitis G, Papamatheakis J: Multiple regulatory regions on the 5′ side of the mouse Eα gene. Proc Natl Acad Sci USA 1988; 85: 3075–3079.
Tsang SY, Nakanishi M, Peterlin BM: B-cell-specific and interferon-γ-inducible regulation of the HLA-DRα gene. Proc Natl Acad Sci USA 1988; 85: 8598–8602.
Koch W, Benoist C, Mathis D: Anatomy of a new B-cell-specific enhancer. Mol Cell Biol 1989; 9: 303–311.
Gorman CM, Moffat LF, Howard BH: Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 1982; 2: 1044–1051.
Calame KL: Mechanisms that regulate immunoglobulin gene expression. Ann Rev Immunol 1985; 3: 159–195.
Dorn A, Bollekens J, Staub A, et al: A multiplicity of CCAAT box-binding proteins. Cell 1987; 50: 863–872.
Hooft van Huijsduijnen R, Bollekens J, Dorn A, et al: Properties of a CCAAT box-binding protein. Nucleic Acids Res 1987; 15: 7265–7281.
Miwa K, Doyle C, Strominger JL: Sequence specific interactions of nuclear factors with conserved sequences of human class II major histocompatibility complex genes. Proc Natl Acad Sci USA 1987; 84: 4939–4943.
Miwa K, Strominger JL: The HLA-DQβ upstream region contains an immunoglobulin like octamer motif that binds cell-type specific nuclear factors. Nucleic Acids Res 1987; 15: 8057–8067.
Boothby M, Liou HC, Glimcher LJ: Differences in DNA sequence specificity among MHC class II X box binding proteins. J Immunol 1989; 142: 1005–1014.
Celada A, Shiga M, Imagawa M, et al: Identification of a nuclear factor that binds to a conserved sequence of the I-Aβ gene. J Immunol 1988; 140: 3995–4002.
Calman AF, Peterlin BM: Evidence for atrans-acting factor that regulates the transcription of class II major histocompatibility complex genes: genetic and functional analysis. Proc Natl Acad Sci USA 1988; 85: 8830–8834.
Dorn A, Fehling HJ, Koch W, et al: Cell control region at the 5′ end of a major histocompatibility complex class II gene: Sequences and factors. Mol Cell Biol 1988; 8: 3975–3987.
Koch W, Camdeias S, Gaurdiola J, et al: An enhancer factor defect in a mutant Burkitt lymphoma cell line. J Exp Med 1988; 167: 1781–1790.
Reith W, Satola S, Herrero Sanchez C, et al: Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding proteins, RF-X. Cell 1988; 53: 897–906.
Sittisombut N: Two distinct nuclear factors bind the conserved regulatory sequences of a rabbit major histocompatibility complex class II gene. Mol Cell Biol 1988; 8: 2034–2041.
Stimac E, Lyons S, Pious D: Transcription of HLA class II genes in the absence of B-cell-specific octamer-binding factor. Mol Cell Biol 1988; 8: 3734–3739.
Boothby M, Gravallese E, Liou HS, et al: A DNA binding protein regulated by IL-4 and by differentiation in B cells. Science 1988; 242: 1559–1562.
Dorn A, Benoist C, Mathis D: New B-lymphocyte-specific enhancer-binding protein. Mol Cell Biol 1989; 9: 312–320.
Sherman PA, Basta PV, Moore TL, et al: Class II box consensus sequences in the HLA-DRα gene: Transcriptional function and interaction with nuclear proteins. Mol Cell Biol 1989; 9: 50–56.
Fried M, Crothers DM: Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis. Nucl Acids Res 1981; 9: 6505–6525.
Siebenlist U, Gilbert W: Contacts betweenE. coli RNA polymerase and an early promoter of phage T7. Proc Natl Acad Sci USA 1980; 77: 122–126.
Dynan WS, Tjian R: Isolation of transcription factors that discriminate between different promoters recognizing RNA polymerase II. Cell 1983; 32: 669–680.
Kadonaga JT, Tjian R: Affinity purification of sequence specific DNA binding proteins. Proc Natl Acad Sci USA 1986; 83: 5889–5893.
Didier DK, Schiffenbauer J, Woulfe SL, et al: Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box. Proc Natl Acad Sci USA 1988; 85: 7322–7326.
Liou HC, Boothby MR, Glimcher LH: Distinct cloned class II MHC DNA binding proteins recognize the X box transcription element. Science 1988; 242: 69–71.
Blanar MA, Boettger EC, Flavell RA: Transcriptional activation of HLA-DRα by interferon γ requires atrans-acting protein. Proc Natl Acad Sci USA 1988; 85: 4672–4676.
Amaldi I, Reith W, Berte C, et al: Induction of HLA class II genes by IFN-γ is transcriptional and requires atrans-acting protein. J Immunol 1989; 142: 999–1004.
Singh H, LeBowitz JH, Baldwin AS, et al: Molecular cloning of an enhancer binding protein: Isolation by screening of an expression library with a recognition site DNA. Cell 1988; 52: 415–423.
dePreval C, Lisowska-Grospierre B, Loche M, et al: Atrans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes. Nature 1985; 318: 291–293.
dePreval C, Hadam MR, Mach B: Regulation of genes for class II antigens in cell lines from patients with severe combined immunodeficiency. N Engl J Med 1988; 318: 1295–1300.
Gladstone P, Pious D: Identification of atrans-acting function regulating HLA-DR expression in DR-negative B-cell variants. Somat Cell Genet 1980; 6: 285–298.
Accolla RS: Human B cell variants immunoselected against a single Ia antigen subset have lost expression of several Ia antigen subsets. J Exp Med 1983; 157: 1053–1058.
Calman AF, Peterlin BM: Mutant human B cell lines deficient in class II major histocompatibility complex transcription. J Immunol 1987; 139: 2489–2495.
Hay N, Takimoto M, Bishop JM: A FOS protein is present in a complex that binds a negative regulator of MYC. Genes Dev 1989; 3: 293–303.
Yang Z, Accolla RS, Pious D, et al: Two distinct genetic loci regulating class II gene expression are defective in human mutant and patient cell lines. EMBO J 1988; 7: 1965–1972.
Larhammar D, Servenius B, Rask L, et al: Characterization of an HLA-DRβ pseudogene. Proc Natl Acad Sci USA 1985; 82: 1475–1479.
Andersson G, Larhammar D, Widmark E, et al: Class II genes of the human major histocompatibility complex: Organization and evolutionary relationship of the DRβ genes. J Biol Chem 1987; 262: 8748–8758.
Tonnelle C, DeMars R, Long EO: DOβ: A new β chain gene in HLA-D with a distinct regulation of expression. EMBO J 1985; 4: 2839–2847.
Wake CT, Flavell RA: Multiple mechanisms regulate the expression of murine immune response genes. Cell 1985; 42: 623–626.
Auffray C, Lillie JW, Korman A, et al: Structure and expression of HLA-DQα and DXα genes: Interallelic alternate splicing of the HLA-DQα gene and functional splicing of the HLA-DXα gene using a retroviral vector. Immunogenetics 1987; 26: 63–73.
Jonsson AK, Hyldig-Nielsen JJ, Servenius B, et al: Class II genes of the human major histocompatibility complex: Comparisons of the DQ and DX α and β genes. J Biol Chem 1987; 262: 8767–8777.
Trowsdale J, Kelly A: The human HLA class II α chain gene DZα is distinct from genes in the DP, DQ, and DR subregions, EMBO J 1985; 4: 2231–2237.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Peterlin, B.M., Andersson, G., Lötscher, E. et al. Transcriptional regulation of HLA class-II genes. Immunol Res 9, 164–177 (1990). https://doi.org/10.1007/BF02918176
Issue Date:
DOI: https://doi.org/10.1007/BF02918176